Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Immutep Ltd (PRRUF)
OTHER OTC:PRRUF
Immutep Ltd (PRRUF) Stock Price & Analysis
17 Followers
PRRUF Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.13 - $0.38
Previous Close$0.2
Volume33.00
Average Volume (3M)12.04K
Market Cap
$248.68M
Enterprise Value$167.00M
Total Cash (Recent Filing)AU$123.42M
Total Debt (Recent Filing)AU$1.23M
Price to Earnings (P/E)―
Beta0.79
Next Earnings
Aug 28, 2024EPS Estimate
-$0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.03
Shares Outstanding1,188,834,559
10 Day Avg. Volume0
30 Day Avg. Volume12,041
Standard Deviation0.34
R-Squared0.00225
Alpha0.06
Financial Highlights & Ratios
Price to Book (P/B)2.65
Price to Sales (P/S)89.56
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$0.66Price Target Upside260.46% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
Immutep Ltd News
PremiumCompany Announcements
Immutep Readies Phase III Lung Cancer Trial
PremiumCompany Announcements
Immutep Set to Begin Landmark Autoimmune Therapy Trial
PremiumCompany Announcements
Perennial Value Management Acquires Immutep Stake
PremiumCompany Announcements
Immutep’s Novel Cancer Therapy Shows Promising Results
PremiumCompany Announcements
Immutep Reports Encouraging TACTI-003 Study DataOwnership Overview
6.44% Insiders
0.01% Mutual Funds
0.09% Other Institutional Investors
93.46% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
PRRUF FAQ
What was Immutep Ltd’s price range in the past 12 months?
Immutep Ltd lowest stock price was $0.13 and its highest was $0.38 in the past 12 months.
What is Immutep Ltd’s market cap?
Currently, no data Available
When is Immutep Ltd’s upcoming earnings report date?
Immutep Ltd’s upcoming earnings report date is Aug 28, 2024 which is in 37 days.
How were Immutep Ltd’s earnings last quarter?
Immutep Ltd released its earnings results on Feb 27, 2024. The company reported -$0.012 earnings per share for the quarter, beating the consensus estimate of -$0.013 by $0.001.
Is Immutep Ltd overvalued?
According to Wall Street analysts Immutep Ltd’s price is currently Undervalued.
Does Immutep Ltd pay dividends?
Immutep Ltd does not currently pay dividends.
What is Immutep Ltd’s EPS estimate?
Immutep Ltd’s EPS estimate is -$0.01.
How many shares outstanding does Immutep Ltd have?
Immutep Ltd has 1,263,136,700 shares outstanding.
What happened to Immutep Ltd’s price movement after its last earnings report?
Immutep Ltd reported an EPS of -$0.012 in its last earnings report, beating expectations of -$0.013. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Immutep Ltd?
Currently, no hedge funds are holding shares in PRRUF
---
Immutep Ltd Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$0.66 (260.46% Upside)
$0.66 (260.46% Upside)
Blogger Sentiment
Bullish
PRRUF Sentiment 97%
Sector Average 72%
Sector Average 72%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-13.27%
12-Months-Change
Fundamentals
Return on Equity
-41.05%
Trailing 12-Months
Asset Growth
44.82%
Trailing 12-Months
Company Description
Immutep Ltd
Immutep Ltd. is a biotechnology company, which engages in the research and development of immunotherapeutic treatments for cancer and autoimmune diseases. Its product is IMP321, which involves in clinical development for the treatment of breast cancer and melanoma. The company was founded on May 21, 1987 and is headquartered in Sydney, Australia.
---
PRRUF Stock 12 Month Forecast
Average Price Target
$0.66
▲(260.46% Upside)
Technical Analysis
Best Analysts Covering PRRUF
1 Year
1 Year Success Rate
4/12 ratings generated profit
1 Year Average Return
-3.28%
reiterated a buy rating 27 days ago
Copying Melissa Benson's trades and holding each position for 1 Year would result in 33.33% of your transactions generating a profit, with an average return of -3.28% per trade.
---